- Patent Title: Use of water-soluble realgar solid dispersion in preparation of erythroid differentiation inducer for bone marrow hematopoietic stem cells and/or bone marrow hematopoietic progenitor cells
-
Application No.: US17046383Application Date: 2019-04-11
-
Publication No.: US11976300B2Publication Date: 2024-05-07
- Inventor: Haiyan Xu , Jian Liu , Tao Wang , Bing Han , Jie Meng , Tao Wen
- Applicant: Institute of Basic Medical Sciences Chinese Academy of Medical Sciences
- Applicant Address: CN Beijing
- Assignee: INSTITUTE OF BASIC MEDICAL SCIENCES CHINESE ACADEMY OF MEDICAL SCIENCES
- Current Assignee: INSTITUTE OF BASIC MEDICAL SCIENCES CHINESE ACADEMY OF MEDICAL SCIENCES
- Current Assignee Address: CN Beijing
- Agency: Scully, Scott, Murphy & Presser, P.C.
- Priority: CN 1810321323.9 2018.04.11
- International Application: PCT/CN2019/082256 2019.04.11
- International Announcement: WO2019/196903A 2019.10.17
- Date entered country: 2020-10-09
- Main IPC: C12N5/078
- IPC: C12N5/078 ; A61K9/14 ; A61K33/36 ; A61P7/00 ; A61P7/02 ; A61P7/06 ; A61P35/02

Abstract:
Disclosed is the use of a water-soluble realgar solid dispersion in the preparation of an erythroid differentiation inducer for bone marrow hematopoietic stem cells and/or bone marrow hematopoietic progenitor cells. The water-soluble realgar solid dispersion is prepared from raw materials comprising 1 part by weight of realgar, 1-20 parts by weight of a polymer, and 0-5 parts by weight of a surfactant. The water-soluble realgar solid dispersion can induce bone marrow hematopoietic stem and/or progenitor cells to be differentiated into red blood cells, promote the accumulation of red blood cells in bone marrow cells, effectively alleviate the decrease in the number of red blood cells caused by the suppression of the erythroid differentiation of bone marrow hematopoietic stem and/or progenitor cells, improve anemia caused by hematopoietic failure, and protect bone marrow cells from the killing effect.
Public/Granted literature
Information query